Industry Research Reports
Global Pharmacogenomics (PGx) Market Research Report 2024
Industry: Machinery & Equipment
Published Date: 2024-01-11
Pages: 90 Pages
Report ld: 2189835
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmacogenomics (PGx) Market Size(US$)
CAGR 2024-2030
9.3%
Market Size,2030
USD 14,590
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 8,569.5 million
Market Forecast in 2030(Value)
US$ 14,590 million
CAGR
9.3%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmacogenomics (PGx) market was valued at US$ 7757.9 million in 2023 and is anticipated to reach US$ 14590 million by 2030, witnessing a CAGR of 9.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacogenomics (PGx), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenomics (PGx).
MARKET SEGMENTATION
By Company
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc
- Astrazeneca
- GeneDX
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pathway Genomics
- Pfizer, Inc
- Qiagen, Inc.
- Rocheg
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Transgenomic, Inc.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Polymerase Chain Reaction (PCR)
- Microarray
- Sequencing
- Other
Segment by Application
- Cardiovascular Diseases (CVD)
- Central Nervous System (CNS)
- Cancer/Oncology
- Infectious Diseases
- Other
REPORT SCOPE
The Pharmacogenomics (PGx) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacogenomics (PGx) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacogenomics (PGx) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacogenomics (PGx) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Microarray
1.2.4 Sequencing
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pharmacogenomics (PGx) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Diseases (CVD)
1.3.3 Central Nervous System (CNS)
1.3.4 Cancer/Oncology
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenomics (PGx) Market Perspective (2019-2030)
2.2 Pharmacogenomics (PGx) Growth Trends by Region
2.2.1 Global Pharmacogenomics (PGx) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacogenomics (PGx) Historic Market Size by Region (2019-2024)
2.2.3 Pharmacogenomics (PGx) Forecasted Market Size by Region (2025-2030)
2.3 Pharmacogenomics (PGx) Market Dynamics
2.3.1 Pharmacogenomics (PGx) Industry Trends
2.3.2 Pharmacogenomics (PGx) Market Drivers
2.3.3 Pharmacogenomics (PGx) Market Challenges
2.3.4 Pharmacogenomics (PGx) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenomics (PGx) Players by Revenue
3.1.1 Global Top Pharmacogenomics (PGx) Players by Revenue (2019-2024)
3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue
3.4 Global Pharmacogenomics (PGx) Market Concentration Ratio
3.4.1 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics (PGx) Revenue in 2023
3.5 Pharmacogenomics (PGx) Key Players Head office and Area Served
3.6 Key Players Pharmacogenomics (PGx) Product Solution and Service
3.7 Date of Enter into Pharmacogenomics (PGx) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics (PGx) Breakdown Data by Type
4.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2019-2024)
4.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2025-2030)
5 Pharmacogenomics (PGx) Breakdown Data by Application
5.1 Global Pharmacogenomics (PGx) Historic Market Size by Application (2019-2024)
5.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacogenomics (PGx) Market Size (2019-2030)
6.2 North America Pharmacogenomics (PGx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacogenomics (PGx) Market Size by Country (2019-2024)
6.4 North America Pharmacogenomics (PGx) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacogenomics (PGx) Market Size (2019-2030)
7.2 Europe Pharmacogenomics (PGx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacogenomics (PGx) Market Size by Country (2019-2024)
7.4 Europe Pharmacogenomics (PGx) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenomics (PGx) Market Size (2019-2030)
8.2 Asia-Pacific Pharmacogenomics (PGx) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacogenomics (PGx) Market Size (2019-2030)
9.2 Latin America Pharmacogenomics (PGx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacogenomics (PGx) Market Size by Country (2019-2024)
9.4 Latin America Pharmacogenomics (PGx) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenomics (PGx) Market Size (2019-2030)
10.2 Middle East & Africa Pharmacogenomics (PGx) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Introduction
11.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Affymetrix, Inc.
11.2.1 Affymetrix, Inc. Company Detail
11.2.2 Affymetrix, Inc. Business Overview
11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Introduction
11.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.2.5 Affymetrix, Inc. Recent Development
11.3 Assurex Health, Inc
11.3.1 Assurex Health, Inc Company Detail
11.3.2 Assurex Health, Inc Business Overview
11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Introduction
11.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.3.5 Assurex Health, Inc Recent Development
11.4 Astrazeneca
11.4.1 Astrazeneca Company Detail
11.4.2 Astrazeneca Business Overview
11.4.3 Astrazeneca Pharmacogenomics (PGx) Introduction
11.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.4.5 Astrazeneca Recent Development
11.5 GeneDX
11.5.1 GeneDX Company Detail
11.5.2 GeneDX Business Overview
11.5.3 GeneDX Pharmacogenomics (PGx) Introduction
11.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.5.5 GeneDX Recent Development
11.6 Illumina, Inc.
11.6.1 Illumina, Inc. Company Detail
11.6.2 Illumina, Inc. Business Overview
11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Introduction
11.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.6.5 Illumina, Inc. Recent Development
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Detail
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.7.5 Laboratory Corporation of America Holdings Recent Development
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Detail
11.8.2 Myriad Genetics, Inc. Business Overview
11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Introduction
11.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.8.5 Myriad Genetics, Inc. Recent Development
11.9 Pathway Genomics
11.9.1 Pathway Genomics Company Detail
11.9.2 Pathway Genomics Business Overview
11.9.3 Pathway Genomics Pharmacogenomics (PGx) Introduction
11.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.9.5 Pathway Genomics Recent Development
11.10 Pfizer, Inc
11.10.1 Pfizer, Inc Company Detail
11.10.2 Pfizer, Inc Business Overview
11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Introduction
11.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.10.5 Pfizer, Inc Recent Development
11.11 Qiagen, Inc.
11.11.1 Qiagen, Inc. Company Detail
11.11.2 Qiagen, Inc. Business Overview
11.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Introduction
11.11.4 Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.11.5 Qiagen, Inc. Recent Development
11.12 Rocheg
11.12.1 Rocheg Company Detail
11.12.2 Rocheg Business Overview
11.12.3 Rocheg Pharmacogenomics (PGx) Introduction
11.12.4 Rocheg Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.12.5 Rocheg Recent Development
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Detail
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Introduction
11.14.4 Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.14.5 Thermo Fisher Scientific Recent Development
11.15 Transgenomic, Inc.
11.15.1 Transgenomic, Inc. Company Detail
11.15.2 Transgenomic, Inc. Business Overview
11.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Introduction
11.15.4 Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024)
11.15.5 Transgenomic, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Microarray
Table 4. Key Players of Sequencing
Table 5. Key Players of Other
Table 6. Global Pharmacogenomics (PGx) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pharmacogenomics (PGx) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pharmacogenomics (PGx) Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Pharmacogenomics (PGx) Market Share by Region (2019-2024)
Table 10. Global Pharmacogenomics (PGx) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Pharmacogenomics (PGx) Market Share by Region (2025-2030)
Table 12. Pharmacogenomics (PGx) Market Trends
Table 13. Pharmacogenomics (PGx) Market Drivers
Table 14. Pharmacogenomics (PGx) Market Challenges
Table 15. Pharmacogenomics (PGx) Market Restraints
Table 16. Global Pharmacogenomics (PGx) Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Pharmacogenomics (PGx) Market Share by Players (2019-2024)
Table 18. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2023)
Table 19. Ranking of Global Top Pharmacogenomics (PGx) Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Pharmacogenomics (PGx) Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmacogenomics (PGx) Product Solution and Service
Table 23. Date of Enter into Pharmacogenomics (PGx) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacogenomics (PGx) Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2019-2024)
Table 27. Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2025-2030)
Table 29. Global Pharmacogenomics (PGx) Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Pharmacogenomics (PGx) Revenue Market Share by Application (2019-2024)
Table 31. Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Pharmacogenomics (PGx) Revenue Market Share by Application (2025-2030)
Table 33. North America Pharmacogenomics (PGx) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Pharmacogenomics (PGx) Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Pharmacogenomics (PGx) Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Pharmacogenomics (PGx) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Pharmacogenomics (PGx) Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Pharmacogenomics (PGx) Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Pharmacogenomics (PGx) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Pharmacogenomics (PGx) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Pharmacogenomics (PGx) Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharmacogenomics (PGx) Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharmacogenomics (PGx) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Pharmacogenomics (PGx) Product
Table 51. Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Affymetrix, Inc. Company Detail
Table 54. Affymetrix, Inc. Business Overview
Table 55. Affymetrix, Inc. Pharmacogenomics (PGx) Product
Table 56. Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 57. Affymetrix, Inc. Recent Development
Table 58. Assurex Health, Inc Company Detail
Table 59. Assurex Health, Inc Business Overview
Table 60. Assurex Health, Inc Pharmacogenomics (PGx) Product
Table 61. Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 62. Assurex Health, Inc Recent Development
Table 63. Astrazeneca Company Detail
Table 64. Astrazeneca Business Overview
Table 65. Astrazeneca Pharmacogenomics (PGx) Product
Table 66. Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 67. Astrazeneca Recent Development
Table 68. GeneDX Company Detail
Table 69. GeneDX Business Overview
Table 70. GeneDX Pharmacogenomics (PGx) Product
Table 71. GeneDX Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 72. GeneDX Recent Development
Table 73. Illumina, Inc. Company Detail
Table 74. Illumina, Inc. Business Overview
Table 75. Illumina, Inc. Pharmacogenomics (PGx) Product
Table 76. Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 77. Illumina, Inc. Recent Development
Table 78. Laboratory Corporation of America Holdings Company Detail
Table 79. Laboratory Corporation of America Holdings Business Overview
Table 80. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product
Table 81. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 82. Laboratory Corporation of America Holdings Recent Development
Table 83. Myriad Genetics, Inc. Company Detail
Table 84. Myriad Genetics, Inc. Business Overview
Table 85. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product
Table 86. Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 87. Myriad Genetics, Inc. Recent Development
Table 88. Pathway Genomics Company Detail
Table 89. Pathway Genomics Business Overview
Table 90. Pathway Genomics Pharmacogenomics (PGx) Product
Table 91. Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 92. Pathway Genomics Recent Development
Table 93. Pfizer, Inc Company Detail
Table 94. Pfizer, Inc Business Overview
Table 95. Pfizer, Inc Pharmacogenomics (PGx) Product
Table 96. Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 97. Pfizer, Inc Recent Development
Table 98. Qiagen, Inc. Company Detail
Table 99. Qiagen, Inc. Business Overview
Table 100. Qiagen, Inc. Pharmacogenomics (PGx) Product
Table 101. Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 102. Qiagen, Inc. Recent Development
Table 103. Rocheg Company Detail
Table 104. Rocheg Business Overview
Table 105. Rocheg Pharmacogenomics (PGx) Product
Table 106. Rocheg Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 107. Rocheg Recent Development
Table 108. Teva Pharmaceutical Industries Ltd. Company Detail
Table 109. Teva Pharmaceutical Industries Ltd. Business Overview
Table 110. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product
Table 111. Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 112. Teva Pharmaceutical Industries Ltd. Recent Development
Table 113. Thermo Fisher Scientific Company Detail
Table 114. Thermo Fisher Scientific Business Overview
Table 115. Thermo Fisher Scientific Pharmacogenomics (PGx) Product
Table 116. Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 117. Thermo Fisher Scientific Recent Development
Table 118. Transgenomic, Inc. Company Detail
Table 119. Transgenomic, Inc. Business Overview
Table 120. Transgenomic, Inc. Pharmacogenomics (PGx) Product
Table 121. Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2019-2024) & (US$ Million)
Table 122. Transgenomic, Inc. Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacogenomics (PGx) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmacogenomics (PGx) Market Share by Type: 2023 VS 2030
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Microarray Features
Figure 5. Sequencing Features
Figure 6. Other Features
Figure 7. Global Pharmacogenomics (PGx) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pharmacogenomics (PGx) Market Share by Application: 2023 VS 2030
Figure 9. Cardiovascular Diseases (CVD) Case Studies
Figure 10. Central Nervous System (CNS) Case Studies
Figure 11. Cancer/Oncology Case Studies
Figure 12. Infectious Diseases Case Studies
Figure 13. Other Case Studies
Figure 14. Pharmacogenomics (PGx) Report Years Considered
Figure 15. Global Pharmacogenomics (PGx) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Pharmacogenomics (PGx) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Pharmacogenomics (PGx) Market Share by Region: 2023 VS 2030
Figure 18. Global Pharmacogenomics (PGx) Market Share by Players in 2023
Figure 19. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2023
Figure 21. North America Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Pharmacogenomics (PGx) Market Share by Country (2019-2030)
Figure 23. United States Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Pharmacogenomics (PGx) Market Share by Country (2019-2030)
Figure 27. Germany Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pharmacogenomics (PGx) Market Share by Region (2019-2030)
Figure 35. China Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Pharmacogenomics (PGx) Market Share by Country (2019-2030)
Figure 43. Mexico Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pharmacogenomics (PGx) Market Share by Country (2019-2030)
Figure 47. Turkey Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Pharmacogenomics (PGx) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 50. Affymetrix, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 51. Assurex Health, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 52. Astrazeneca Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 53. GeneDX Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 54. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 55. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 57. Pathway Genomics Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 58. Pfizer, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 59. Qiagen, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 60. Rocheg Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 63. Transgenomic, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 9.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Pharmacogenomics (PGx) market size from 2024 to 2030?
Which companies rank high in the global Pharmacogenomics (PGx) market?
What was the global market size of Pharmacogenomics (PGx) in 2024?
What was the global market size of Pharmacogenomics (PGx) in 2030?
Related Reports
Pharmacogenomics (PGx) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmacogenomics (PGx) was estimated to be worth US$ 10060 million in 2025 and is projected to reach US$ 18570 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 114
USD 3950.00
(Single User License)
Global Pharmacogenomics (PGx) Market Research Report 2026
The global Pharmacogenomics (PGx) market was valued at US$ 10060 million in 2025 and is anticipated to reach US$ 18570 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 113
USD 2900.00
(Single User License)
Global Pharmacogenomics (PGx) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacogenomics (PGx) market is projected to grow from US$ 9285 million in 2024 to US$ 17130 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-30
Pages: 142
USD 4900.00
(Single User License)
Global Pharmacogenomics (PGx) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacogenomics (PGx) market size was US$ 9285 million in 2024 and is forecast to a readjusted size of US$ 17130 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 93
USD 4250.00
(Single User License)
Pharmacogenomics (PGx)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacogenomics (PGx) was estimated to be worth US$ 9285 million in 2024 and is forecast to a readjusted size of US$ 17130 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 105
USD 3950.00
(Single User License)
Global Pharmacogenomics (PGx) Market Research Report 2025
The global market for Pharmacogenomics (PGx) was valued at US$ 9285 million in the year 2024 and is projected to reach a revised size of US$ 17130 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-02-25
Pages: 84
USD 2900.00
(Single User License)
Global Pharmacogenomics (PGx) Market Insights, Forecast to 2030
Market Analysis and Insights: Global Pharmacogenomics (PGx) Market
Published Date: 2024-04-25
Pages: 119
USD 4900.00
(Single User License)
Pharmacogenomics (PGx) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmacogenomics (PGx) was estimated to be worth US$ 10060 million in 2025 and is projected to reach US$ 18570 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-07-15
Pages: 114
USD 3950.00 (Single User License)Global Pharmacogenomics (PGx) Market Research Report 2026
The global Pharmacogenomics (PGx) market was valued at US$ 10060 million in 2025 and is anticipated to reach US$ 18570 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 113
USD 2900.00 (Single User License)Global Pharmacogenomics (PGx) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacogenomics (PGx) market is projected to grow from US$ 9285 million in 2024 to US$ 17130 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-30
Pages: 142
USD 4900.00 (Single User License)Global Pharmacogenomics (PGx) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacogenomics (PGx) market size was US$ 9285 million in 2024 and is forecast to a readjusted size of US$ 17130 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 93
USD 4250.00 (Single User License)Pharmacogenomics (PGx)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacogenomics (PGx) was estimated to be worth US$ 9285 million in 2024 and is forecast to a readjusted size of US$ 17130 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 105
USD 3950.00 (Single User License)Global Pharmacogenomics (PGx) Market Research Report 2025
The global market for Pharmacogenomics (PGx) was valued at US$ 9285 million in the year 2024 and is projected to reach a revised size of US$ 17130 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-02-25
Pages: 84
USD 2900.00 (Single User License)Global Pharmacogenomics (PGx) Market Insights, Forecast to 2030
Market Analysis and Insights: Global Pharmacogenomics (PGx) Market
Published: 2024-04-25
Pages: 119
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now